March 18th 2024
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Study: Antibiotic therapy reduces intraamniotic inflammation in second trimester idiopathic bleeding
March 1st 2024A recent study revealed the efficacy of antibiotic therapy in reducing intraamniotic inflammation among patients experiencing idiopathic bleeding in the second trimester of pregnancy, shedding light on potential management strategies for this condition.
Read More
FDA approves enmetazobactam for treatment of cUTIs
February 23rd 2024Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.
Read More
Open vs minimally invasive hysterectomy outcomes with enhanced recovery after surgery
February 21st 2024Discover how immediate postoperative symptom burden varies between open and minimally invasive hysterectomies under enhanced recovery after surgery protocols, shedding light on recovery disparities in gynecologic surgery.
Read More
Study finds relugolix-CT Improves HMB in Black women
February 19th 2024Recent research highlights the efficacy and safety of relugolix combination therapy in managing uterine fibroid-associated heavy menstrual bleeding specifically among Black women, demonstrating outcomes comparable to the broader population.
Read More
Study on PCOS and suicide risk reveals correlation
February 9th 2024A recent study revealed an 8.47-fold increased risk of suicide attempts among individuals with polycystic ovary syndrome, prompting the need for proactive mental health management in patients and improved tools for assessing health-related quality-of-life.
Read More
Urodynamics and the role of lidocaine
February 5th 2024Explore the potential benefits and considerations of utilizing intraurethral lidocaine jelly during urodynamic studies for bladder testing, as we delve into research findings on patient discomfort, voiding metrics, and diagnostic precision.
Read More
The impact of physician awareness on decision-making preferences in urogynecology
January 16th 2024A recent study revealed that physician awareness of patients' desired level of decision-making significantly enhances satisfaction, highlighting the importance of tailored approaches for women with pelvic floor disorders seeking patient-centered care.
Read More
Elevated bilateral salpingo-oophorectomy rates in women with disabilities
December 14th 2023A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.
Read More
FDA grants IND clearance to DARE-VVA1 for dyspareunia
December 7th 2023Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Early intrauterine balloon tamponade and severe postpartum hemorrhage risk
November 14th 2023A recent study indicates that early use of intrauterine balloon tamponade does not significantly reduce severe postpartum hemorrhage risk compared to its application after second-line uterotonic treatment failure.
Read More
Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives
November 8th 2023In a recent study, patients who were treated for heavy menstrual bleeding with the levonorgestrel intrauterine system had similar changes in bleeding-related quality of life as those using combined oral contraceptives for treatment.
Read More